Vita Dora Iula
Overview
Explore the profile of Vita Dora Iula including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stabile M, Esposito A, Iula V, Guaragna A, De Gregorio E
Pathogens
. 2023 Nov;
12(11).
PMID: 38003788
Antibiotic resistance has become more and more widespread over the recent decades, becoming a major global health problem and causing colistin to be increasingly used as an antibiotic of last...
2.
Esposito A, Migliaccio A, Iula V, Zarrilli R, Guaragna A, De Gregorio E
Antibiotics (Basel)
. 2021 Nov;
10(11).
PMID: 34827334
Invasive infections have become a global public health problem due to the increase of species resistant against antifungal therapeutics. The glucocorticoid PYED-1 (pregnadiene-11-hydroxy-16α,17α-epoxy-3,20-dione-1) has antimicrobial activity against various bacterial taxa....
3.
Durante-Mangoni E, Gambardella M, Iula V, De Stefano G, Corrado M, Esposito V, et al.
Int J Antimicrob Agents
. 2020 Jul;
56(4):106107.
PMID: 32721599
Dalbavancin is a novel lipoglycopeptide antibiotic with a chemical structure similar to teicoplanin. Dalbavancin has been approved and marketed since 2014 in the USA and 2015 in the European Union...
4.
De Gregorio E, Esposito A, Vollaro A, De Fenza M, DAlonzo D, Migliaccio A, et al.
Antibiotics (Basel)
. 2020 Jul;
9(6).
PMID: 32604791
is one of the major causes of hospital- and community-associated bacterial infections throughout the world, which are difficult to treat due to the rising number of drug-resistant strains. New molecules...
5.
Vollaro A, Esposito A, Antonaki E, Iula V, DAlonzo D, Guaragna A, et al.
Microorganisms
. 2020 Mar;
8(4).
PMID: 32218320
In this work, the antibacterial activity of deflazacort and several of its synthetic precursors was tested against a panel of bacterial pathogens responsible for most drug-resistant infections including spp., ,...
6.
Cerchione C, Martinelli G, Pedatella S, De Nisco M, Pugliese N, Manfra M, et al.
Anticancer Drugs
. 2019 Oct;
31(1):67-72.
PMID: 31633499
Cytarabine, the 4-amino-1-(β-D-arabinofuranosyl)-2(1H)-pyrimidinone, (ARA-C) is an antimetabolite cytidine analogue used worldwide as key drug in the management of leukaemia. As specified in the manufacturers' instructions, once the components-sterile water and...
7.
Viceconte G, Maraolo A, Iula V, Catania M, Tosone G, Orlando R
Infez Med
. 2017 Sep;
25(3):224-233.
PMID: 28956539
A huge proportion of antibiotic therapies for infections caused by multidrug-resistant bacteria (MDR) are inappropriate. In this study, we described the most common causes of inappropriateness of definitive antibiotic regimes...
8.
Garzillo C, Bagattini M, Bogdanovic L, Di Popolo A, Iula V, Catania M, et al.
Ital J Pediatr
. 2017 Mar;
43(1):10.
PMID: 28257640
Background: Candida parapsilosis is increasingly responsible for invasive candidiasis in neonates. This study investigates phenotypic and genotypic features of C. parapsilosis microbial isolates and underlying clinical conditions associated with acquisition...
9.
Pulcrano G, Pignanelli S, Vollaro A, Esposito M, Iula V, Roscetto E, et al.
APMIS
. 2016 Mar;
124(6):516-21.
PMID: 27004836
Enterobacter aerogenes has recently emerged as an important hospital pathogen. In this study, we showed the emergence of E. aerogenes isolates carrying the blaKPC gene in patients colonized by carbapenem-resistant...
10.
Pignanelli S, Pulcrano G, Iula V, Shurdhi A
Indian J Microbiol
. 2015 Jun;
55(3):345-8.
PMID: 26063946
Chlamydophila pneumoniae is a pathogenic agent, involved in various types of infection. This study has evaluated the ability of IgG antibodies in outpatient, with acute respiratory tract infections from C....